Aikido pharma announces positive phase 1 data presented at asco on 225ac-j591

New york, june 4, 2021 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today announced that positive phase 1 testing data was presented at the 2021 asco annual meeting june 4, 2021.  the poster presentation of the data was by dr. scott tagawa, a professor of medicine & urology at weill cornell medicine and an aikido pharma scientific advisory board member.
DOMH Ratings Summary
DOMH Quant Ranking